top
Search terms
Results 1 - 10 of 14 - ordered by :
Pages: 1 2
ESC365

Residual stroke risk of anticoagulated patients with atrial fibrillation: PREFER in AF European registry.

Date : 28/08/2017
ESC365

Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.

Date : 28/08/2017
ESC365

Serial IL-6 levels and risk of death in anticoagulated patients with atrial fibrillation:

Date : 28/08/2017
ESC365

Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation

Date : 18/06/2017
ESC365

NETosis markers are predictors for adverse events in anticoagulated patients with atrial fibrillation

Date : 30/08/2016
Escardio

14:00 P2586 Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trial Denis XAVIER (Bangalore, ...

Poster session 3: Anticoagulation in atrial fibrillation III

Date : 28/08/2016 Item size : 127195 bytes
ESC365

Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation

Date : 02/09/2014